The quorum-sensing molecule N-3-oxododecanoyl homoserine lactone (3OC12-HSL) enhances the host defence by activating human polymorphonuclear neutrophils (PMN)

  • Christof Wagner
  • Sabine Zimmermann
  • Gerald Brenner-Weiss
  • Friederike Hug
  • Birgit Prior
  • Ursula Obst
  • Gertrud Maria Hänsch
Original Paper

Abstract

The P. aeruginosa quorum-sensing molecule N-3-oxododecanoyl homoserine lactone (3OC12-HSL) interacts not only with bacteria, but also with mammalian cells, among others with those of the immune defence system. We focussed on the possible interaction of 3OC12-HSL with human polymorphonuclear neutrophils (PMN), because these cells are the first to enter an infected site. We found that 3OC12-HSL attracts PMN, and up-regulates expression of receptors known to be involved in host defence, including the adhesion proteins CD11b/CD18 and the immunoglobulin receptors CD16 and CD64. Furthermore, the uptake of bacteria (phagocytosis), which is crucial for an efficient defence against infection, was enhanced. Thus, recognising and responding to 3OC12-HSL not only attracts the PMN to the site of a developing biofilm, but also reinforces their defence mechanisms, and hence could be a means to control the infection in an early stage and to prevent biofilm formation.

Keywords

Quorum sensing PMN Functional activity Homoserine lactone Host defence 

References

  1. 1.
    Costerton W, Veeh R, Shirtliff M, Pasmore M, Post C, Ehrlich G (2003) J Clin Invest 112:1466–1477CrossRefGoogle Scholar
  2. 2.
    Hall-Stoodley L, Costerton JW, Stoodley P (2004) Nat rev Microbiol 2:95–108CrossRefGoogle Scholar
  3. 3.
    Wiblin RT (1997) In: Wenzel RP (ed) Prevention and control of nosocomial infections, 3rd edn. Williams and Wilkins, BaltimoreGoogle Scholar
  4. 4.
    Smith RS, Iglewski BH (2003) Curr Oppin Microbiol 6:56–60CrossRefGoogle Scholar
  5. 5.
    Head NE, Yu H (2004) Infect Immun 72:133–144CrossRefGoogle Scholar
  6. 6.
    van Delden C, Iglewski BH (1998) Emerg Infect Dis 4:551–560CrossRefGoogle Scholar
  7. 7.
    DiMango E, Zar HJ, Bryan R, Prince A (1995) J Clin Invest 96:2204–2210Google Scholar
  8. 8.
    Smith RS, Fedyk Er, Springer TA, Mukaida N, Iglewski BH, Phipps RP (2001) J Immunol 167:366–374Google Scholar
  9. 9.
    Chun CK, Ozer EA, Welsh MJ, Zabner J, Greenberg EP (2004) PNAS 110:3587–3590CrossRefGoogle Scholar
  10. 10.
    Telford G, Wheeler D, Williams P, Tomkins PT, Appleby P, Sewell H, Stewart GS, Bycroft BW, Pritchard DI (1998) Infect Immun 66:36–42Google Scholar
  11. 11.
    Smith RS, Harris SG, Phipps R, Iglewski B (2002) J Bacteriol 184:1132–1139CrossRefGoogle Scholar
  12. 12.
    Ritchie AJ, Yam AO, Tanabe KM, Rice SA, Cooley MA (2003) Infect Immun 71:4421–4431CrossRefGoogle Scholar
  13. 13.
    Chhabra SR, Harty C, Hoii DSW, Daykin M, Williams P, Telford G, Pritchard DI, Bycroft BW (2003) J Med Chem 46:97–104CrossRefGoogle Scholar
  14. 14.
    Hooi DSW, Bycroft BW, Chhabra SR, Williams P, Pritchard DI (2004) Infect Immun 72:6463–6470CrossRefGoogle Scholar
  15. 15.
    Vikström E, Magnusson KE, Pivoriunas A (2005) Microbes Infect 7:1512–1518CrossRefGoogle Scholar
  16. 16.
    Zimmermann S, Wagner C, Müller W, Brenner-Weiss G, Hug F, Prior B, Obst U, Hänsch GM (2006) Infect Immun (submitted)Google Scholar
  17. 17.
    Medzhitov R, Janeway C Jr (2000) Trends Microbiol 8:452–456CrossRefGoogle Scholar
  18. 18.
    Gallucci S, Matzinger P (2001) Curr Opin Immunol 13:114–119CrossRefGoogle Scholar
  19. 19.
    Hargreaves DC, Medzhitov R (2005) J Clin Immunol 25:503–510CrossRefGoogle Scholar
  20. 20.
    Heine H, Ulmer AJ (2005) Chem Immunol Allergy 86:99–119CrossRefGoogle Scholar
  21. 21.
    Tateda K, Ishii Y, Horikawa M, Matsumoto T, Miyairi S, Pechere JC, Standiford TJ, Ishiguro M, Yamaguchi K (2003) Infect Immun 71:5785–5793CrossRefGoogle Scholar
  22. 22.
    Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P, Lacombe F (1994) Cytometry 17:59–65CrossRefGoogle Scholar
  23. 23.
    Brenneis H, Schmidt A, Blaas-Mautner P, Wörner I, Ludwig R, Hänsch GM (1993) Eur J Invest 23:693–698Google Scholar
  24. 24.
    Babior BM, Kipnes RS, Curnutte JT (1973) J Clin Invest 52:741–744CrossRefGoogle Scholar
  25. 25.
    Leid JG, Shirtliff ME, Costerton JW, Stoodley AP (2002) Infect Immun 70:6339–6345CrossRefGoogle Scholar
  26. 26.
    Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, Duffy JE, Beyenal H, Lewandowsky Z (2003) J Immunol 171:4329–4339Google Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Christof Wagner
    • 1
    • 2
  • Sabine Zimmermann
    • 1
  • Gerald Brenner-Weiss
    • 3
  • Friederike Hug
    • 1
  • Birgit Prior
    • 1
  • Ursula Obst
    • 3
  • Gertrud Maria Hänsch
    • 1
  1. 1.Institut für Immunologie der Universität HeidelbergHeidelbergGermany
  2. 2.Klinik für Unfall- und WiederherstellungschirurgieBerufsgenossenschaftliche Unfallklinik LudwigshafenLudwigshafenGermany
  3. 3.Institut für Technische ChemieForschungszentrum KarlsruheEggenstein-LeopoldshafenGermany

Personalised recommendations